Navigation Links
New Clues to Stopping Colitis-Linked Cancer
Date:2/2/2009

2 immune system proteins could hold the key, study finds

MONDAY, Feb 2 (HealthDay News) -- Two immune system proteins may someday help doctors treat and prevent colitis-associated cancer (CAC), a new study suggests.

The Interleukin 6 (IL-6) cytokine, a protein released by cells in the immune system, plays a key role in tumor production of colitis-associated cancer, according to a study on mice done at the University of California, San Diego, School of Medicine. This work by IL-6 appears dependent on STAT3, a transcription factor that encourages cancer development, according to the findings published in the Feb. 3 online edition of Cancer Cell.

The findings suggest that targeting IL-6 and Stat3 mught be a way to stop or treat CAC, said lead researcher Michael Karin, a professor of pharmacology and pathology at the university and a member of its cancer center. For example, when researchers removed STAT3 from intestinal epithelial cells, the development of colitis-associated cancer stopped in the mice.

Inflammatory bowel disease, such as ulcerative colitis, puts people at a greater risk of developing colorectal cancer. Nearly half of people with the malignancy die from it.

The new study backs previous work by the San Diego researchers, who suspected that IL-6 helped foster chronic inflammation and the survival of malignant cells that helped promote cancer.

More information

The U.S. National Cancer Institute has more about colorectal cancer.



-- Kevin McKeever



SOURCE: University of California - San Diego, news release, Feb. 2, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
2. Online Epidemic Gives Clues to Bird Flu Spread
3. New knock-out gene model provides molecular clues to breast cancer
4. New clues to breast cancer development in high-risk women
5. Clues to Cell Death Could Fight Disease
6. Genes Give Clues to Newborn Lung Disease
7. Mouse Study Gives Clues to Colitis
8. VivoMetrics LifeShirt Going to South Pole to Uncover Clues to High-Altitude Illness
9. Protein Gives Clues to Pancreatic Cancer
10. A longer-living, healthier mouse that could hold clues to human aging
11. Clues to ensuring anti-HIV drugs are taken in Africa
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Clues to Stopping Colitis-Linked Cancer
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric ... in their patients. Research shows that the Goal Attainment Scale (GAS) captures 20% ... this challenge and learn more about the Goal Attainment Scale, Education Resources Inc. ...
(Date:2/10/2016)... ... 2016 , ... A national ergonomics pioneer , HealthPostures, ... March 9-11, 2016. Hosted by Ohio's Bureau of Worker's Compensation, the expo will ... running and largest worker's compensation event in Ohio, organizers of the safety congress ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has ... readily available to physicians. The integration will enable Allscripts users to post ... via Everseat’s free mobile app. , The partnership gives Everseat substantial added power ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... UNF Drive, Jacksonville, FL 32224, February 26th: Amateur & Professional Divisions - ... - Time: 7:00pm – 10:00pm | Ticket Prices $30, Social Media: ...
(Date:2/10/2016)... CA (PRWEB) , ... February 10, 2016 , ... Workrite ... based company that has evolved from humble beginnings to being an internationally recognized leader ... company that we are today”, said Charlie Lawrence, President of Workrite. “Workrite recognized ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Feb. 10, 2016 CSI Specialty Group (CSI) ... launch of the Specialty Pharmacy Podcast. A free, weekly ... at providing real-world education, discussion and context amongst specialty ... --> The Specialty Pharmacy Podcast, ... CSI Specialty Group Suzette DiMascio, CHE, CMCE, CPC, is ...
(Date:2/10/2016)... MINNEAPOLIS , Feb. 10, 2016 Urologix, ... for the treatment of Benign Prostatic Hyperplasia (BPH), announces ... Ash Keswani , a medical device industry veteran ... of the Limited Liability Company.  ... and service lines, Cooled ThermoTherapy™ and Prostiva® RF Therapy, ...
(Date:2/10/2016)... Feb. 10, 2016  Oxis International Inc. (OTC/QB: OXIS) ... was described as a "clinical trial triumph" after one ... into complete cancer remission. Daniel Vallera ... Masonic Cancer Center. --> Daniel Vallera ... Masonic Cancer Center. --> An article ...
Breaking Medicine Technology: